Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

McGill University

$17,500.00

The Impact of Investments in Tuberculosis Care Overseas on its Elimination in Canada

EF 2023-24

Résumé
Title: The Impact of Investments in Tuberculosis Care Overseas on its Elimination in Canada Tuberculosis (TB) is the world's leading cause of death due to a single infection. It accounts for 1.7 million deaths worldwide each year—more than COVID or HIV. Nearly 75% of all people who develop TB disease in Canada were born abroad, and cases in these individuals usually reflect the reactivation of dormant TB infections acquired in their home countries. We hope to determine the degree to which investments in TB prevention programs in countries where TB is common will ultimately reduce the TB burden in Canada by (1) lowering the prevalence of dormant TB infection among future immigrants and (2) reducing the risk of immigrants becoming infected with TB when they visit their home countries. These benefits are of course in addition to those experienced by those living in the countries where investments are made. We will estimate the potential impact of reducing TB in several key countries on the health and costs to Canadians using a complex computer simulation model developed by our lab. More specifically, we will predict the numbers of TB cases, related deaths, and costs in Canada if current conditions and strategies continue through 2050. We will then predict the changes in TB cases, deaths, and costs expected over the same period if there are investments made in strategies that reduce TB transmission and improve the diagnosis and treatment of TB infection. Our results will help guide health policy and care for TB by identifying prevention and treatment strategies that are as beneficial and cost-effective as possible for persons both inside and outside Canada.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
506142
Name
King Lauren J
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
The Impact of Investments in Tuberculosis Care Overseas on its Elimination in Canada
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Decision Analysis Modelling; Latent Tuberculosis Infection; Ltbi; Overseas Investments; Return On Investment; Tuberculosis; Tuberculosis Elimination
Abstract
Title: The Impact of Investments in Tuberculosis Care Overseas on its Elimination in Canada Tuberculosis (TB) is the world's leading cause of death due to a single infection. It accounts for 1.7 million deaths worldwide each year—more than COVID or HIV. Nearly 75% of all people who develop TB disease in Canada were born abroad, and cases in these individuals usually reflect the reactivation of dormant TB infections acquired in their home countries. We hope to determine the degree to which investments in TB prevention programs in countries where TB is common will ultimately reduce the TB burden in Canada by (1) lowering the prevalence of dormant TB infection among future immigrants and (2) reducing the risk of immigrants becoming infected with TB when they visit their home countries. These benefits are of course in addition to those experienced by those living in the countries where investments are made. We will estimate the potential impact of reducing TB in several key countries on the health and costs to Canadians using a complex computer simulation model developed by our lab. More specifically, we will predict the numbers of TB cases, related deaths, and costs in Canada if current conditions and strategies continue through 2050. We will then predict the changes in TB cases, deaths, and costs expected over the same period if there are investments made in strategies that reduce TB transmission and improve the diagnosis and treatment of TB infection. Our results will help guide health policy and care for TB by identifying prevention and treatment strategies that are as beneficial and cost-effective as possible for persons both inside and outside Canada.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
King, Lauren J
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~